Found 1831 matches for
Participants in South Africa’s first clinical trial for a vaccine against COVID-19 are to be vaccinated this week.
Group B streptococcus (GBS) is an important cause of meningitis and sepsis in babies, affecting approximately 1 in 1000 live births in the United Kingdom.
Pneumonia accounts for 15% of deaths among children under-5 years of age globally. The burden of disease is especially high in South Asia, where one in four children suffer an episode of pneumonia every year. Streptococcus pneumoniae is one of the most significant causative pathogens of pneumonia and other serious invasive diseases.
The devastating 2013-2015 outbreak of Ebola Virus disease in West Africa provided the impetus for acceleration of multiple programmes of Ebola Vaccine development.
Neisseria meningitidis (Meningitis) is the cause of around 500,000 cases of meningitis and septicaemia every year and disproportionately affects children under two years. We have created new vaccines against MenB. To do this, we have characterised their immunogenicity, identified the optimal vaccine regimen, and evaluated their protective efficacy.
RSV infection is the most important cause of hospitalisation in infants and one of the leading global causes of infant mortality and as such its prevention through immunisation is a public health priority.
Independent information about vaccines and infectious diseases (http://vk.ovg.ox.ac.uk)
Our aim is to understand disease pathogenesis and host responses to infection and vaccination.